Neurological Adverse Effects Due to Programmed Death (PD-1) Inhibitors

被引：0
|
作者：
Shi, Siyu [1 ]
Kanwar, Ruhi [1 ]
Varanasi, Vamsi [1 ]
Eisinger, Ella [1 ]
Thomas, Reena [1 ]
Moore, Justin [2 ]
机构：
[1] Stanford Canc Ctr, Stanford, CA USA
[2] Harvard Med Sch, Neurosurg, Boston, MA 02115 USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.6-020
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neurological adverse effects due to programmed death 1 (PD-1) inhibitors
    Siyu Shi
    Joseph Abi Jaoube
    Ruhi Kanwar
    Michael C. Jin
    Alvaro Amorin
    Vamsi Varanasi
    Ella Eisinger
    Reena Thomas
    Justin M. Moore
    Journal of Neuro-Oncology, 2020, 148 : 291 - 297
  • [2] Neurological adverse effects due to programmed death 1 (PD-1) inhibitors
    Shi, Siyu
    Jaoube, Joseph Abi
    Kanwar, Ruhi
    Jin, Michael C.
    Amorin, Alvaro
    Varanasi, Vamsi
    Eisinger, Ella
    Thomas, Reena
    Moore, Justin M.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (02) : 291 - 297
  • [3] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: a population-based study
    Lee, S.
    Zhou, J.
    Lakhani, I
    Yang, L.
    Liu, T.
    Zhang, Y.
    Xia, Y.
    Wong, W. T.
    Chan, E. W. Y.
    Wong, I. C. K.
    Tse, G.
    Zhang, Q.
    EUROPEAN HEART JOURNAL, 2022, 43
  • [4] Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies
    Kao, Justin C.
    Liao, Bing
    Markovic, Svetomir N.
    Klein, Christopher J.
    Naddaf, Elie
    Staff, Nathan P.
    Liewluck, Teerin
    Hammack, Julie E.
    Sandroni, Paola
    Finnes, Heidi
    Mauermann, Michelle L.
    JAMA NEUROLOGY, 2017, 74 (10) : 1216 - 1222
  • [5] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Justin C. Kao
    Adipong Brickshawana
    Teerin Liewluck
    Current Neurology and Neuroscience Reports, 2018, 18
  • [6] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Kao, Justin C.
    Brickshawana, Adipong
    Liewluck, Teerin
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (10)
  • [7] Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
    Zhou, Yanting
    Li, Hongyan
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [8] Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
    Li, Qiao
    Quan, Lina
    Lyu, Jiankun
    He, Zenghui
    Wang, Xia
    Meng, Jiajia
    Zhao, Zhenjiang
    Zhu, Lili
    Liu, Xiaofeng
    Li, Honglin
    ONCOTARGET, 2016, 7 (40) : 64967 - 64976
  • [9] Adverse reactions to PD-1 inhibitors
    Cox, C.
    Abdel-Malek, L.
    Ng, J.
    Peters, P.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 51 - 51
  • [10] Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses
    Zhou, J.
    Chauy, Y. -L. A.
    Yooy, J. W.
    Lee, S.
    Ng, K.
    Dee, E. C.
    Liu, T.
    Wai, A. K. C.
    Zhang, Q.
    Tse, G.
    CLINICAL ONCOLOGY, 2022, 34 (07) : E316 - E317
12345